tiprankstipranks
Trending News
More News >
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market

Foghorn Therapeutics (FHTX) Income Statement

Compare
413 Followers

Foghorn Therapeutics Income Statement

Last quarter (Q3 2025), Foghorn Therapeutics's total revenue was $8.15M, an increase of 4.42% from the same quarter last year. In Q3, Foghorn Therapeutics's net income was $-15.85M. See Foghorn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 22.60M$ 34.16M$ 19.23M$ 1.32M$ 430.00K
Gross Profit
$ 22.60M$ 34.16M$ 19.23M$ 1.32M$ -57.28M
Operating Expenses
$ 125.28M$ 142.06M$ 136.37M$ 102.05M$ 11.25M
Depreciation and Amortization
$ 3.12M$ 3.45M$ 3.32M$ 3.23M$ 1.33M
EBITDA
$ -97.17M$ -104.45M$ -113.82M$ -96.19M$ -67.20M
Operating Income
$ -102.68M$ -107.91M$ -117.14M$ -100.73M$ -68.53M
Other Income/Expenses
$ 16.06M$ 13.71M$ 8.26M$ -586.00K$ -269.00K
Pretax Income
$ -86.62M$ -94.20M$ -108.88M$ -101.32M$ -68.80M
Net Income
$ -86.62M$ -98.43M$ -108.88M$ -101.32M$ -68.80M
Per Share Metrics
Basic EPS
$ -1.58$ -2.34$ -2.62$ -2.78$ -1.90
Diluted EPS
$ -1.58$ -2.34$ -2.62$ -2.78$ -1.90
Weighted Average Shares Outstanding
54.90M 41.97M 41.59M 37.17M 36.79M
Weighted Average Shares Outstanding (Diluted)
54.90M 41.97M 41.59M 37.17M 36.79M
Currency in USD

Foghorn Therapeutics Earnings and Revenue History